Characterization of a LILRB3 SNP cluster and its link to kidney transplant outcomes
Official title: Characterization of a LILRB3 SNP cluster in kidney transplant recipients associated with post-transplant renal failure
Funded at Icahn School of Medicine at Mount Sinai · NIH-11434426 · Data updated 2026-11-12
A study in kidney transplant recipients looks at genetic factors that may be tied to higher risk of graft failure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 15, 2026 |
| Project end | May 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $910,670 |
| NIH project number | 1R01DK149129-01 |
| Project ID | NIH-11434426 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults who have received a kidney transplant and carry or are suspected to carry LILRB3 SNP variants, or have suspected alloimmune-related risks.
✕Less likely to help
Patients without the LILRB3 SNP cluster or without post-transplant risk factors may see limited benefit.
What this research studies
This project will examine a cluster of LILRB3 gene SNPs that have been linked to poorer kidney transplant results by analyzing patient blood and transplant data across multiple centers. Researchers will relate genetic variants to immune signaling pathways and kidney function after transplantation. The goal is to understand whether these genetic differences help explain why some patients experience graft failure despite similar clinical factors. The study builds on previous findings and will use RNA sequencing and clinical data to explore these associations. Results could point toward new biomarkers or targets to improve graft survival for affected patients.
Why it matters
Potential benefit: If successful, the findings could lead to better risk stratification and personalized management to improve graft survival in patients with these genetic variants.
How similar studies have gone: Earlier work linked LILRB3 SNPs to post-transplant outcomes and immune signaling, with validation in external cohorts.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Zhang, Weijia — Icahn School of Medicine at Mount Sinai
- Study coordinator: Zhang, Weijia
Related research
Other NIH-funded projects on the same topics.
-
Microbial clues to diagnose and predict infections in kidney transplant patients
A patient-focused project will look for microbial biomarkers in stool, blood, and urine to help doctors predict and diagnose infections in people who have had a kidney transplant.
-
Immunological mechanisms behind treatment-resistant kidney transplant rejection
This grant explores why certain kidney transplant rejections don’t respond to standard treatments and what immune cells in the graft are driving that resistance.
-
Complement-Bound Exosomes and Kidney Transplant Immunity
This project studies how kidney transplant injury and rejection happen after surgery and whether blocking certain immune pathways during organ preservation could improve transplant outcomes.
-
Blood vessel signals predicting heart problems after kidney transplant
This project studies blood markers and tissue patterns after kidney transplants to identify which patients are at highest risk of cardiovascular problems.
-
Understanding how BK virus links infection to kidney transplant rejection
This project looks at how BK polyomavirus reactivation affects kidney transplant patients and aims to use pre-transplant T cell information to tailor immunosuppression and monitoring.
-
Optimizing a prehabilitation program for kidney transplant candidates on dialysis
A program to improve physical function and readiness for kidney transplant in people on dialysis is being developed and tested to help candidates stay healthier while they wait.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.